Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Jacobson

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Annals of Internal Medicine|February 1, 1990
Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS)M A Jacobson, T G Berger, S Fikrig, et al.
American Journal of Respiratory Cell and Molecular Biology|May 1, 1997
Adenosine A3 receptor expression and function in eosinophilsB A Walker, M A Jacobson, D A Knight, et al.
Lancet (London, England)|May 17, 1997
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapyM A Jacobson, M Zegans, P R Pavan, et al.
The Journal of Infectious Diseases|June 1, 1991
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDSM A Jacobson, W L Drew, J Feinberg, et al.
The Journal of Infectious Diseases|January 1, 1996
Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infectionG E Harb, J W Mandema, T Delahunty, et al.
Journal of Acquired Immune Deficiency Syndromes|May 1, 1993
An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV diseaseT S Dyner, W Lang, J Geaga, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendationsF T Aweeka, M A Jacobson, S Martin-Munley, et al.
Lancet (London, England)|February 8, 1992
Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDSM A Jacobson, C L Besch, C Child, et al.
AIDS (London, England)|January 11, 2000
A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjectsJ B Angel, M A Jacobson, P R Skolnik, et al.
Neuroscience|September 11, 2002
Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptorsW-P Wu, J-X Hao, L Halldner-Henriksson, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Annals of Internal Medicine|February 1, 1990
Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS)M A Jacobson, T G Berger, S Fikrig, et al.
American Journal of Respiratory Cell and Molecular Biology|May 1, 1997
Adenosine A3 receptor expression and function in eosinophilsB A Walker, M A Jacobson, D A Knight, et al.
Lancet (London, England)|May 17, 1997
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapyM A Jacobson, M Zegans, P R Pavan, et al.
The Journal of Infectious Diseases|June 1, 1991
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDSM A Jacobson, W L Drew, J Feinberg, et al.
The Journal of Infectious Diseases|January 1, 1996
Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infectionG E Harb, J W Mandema, T Delahunty, et al.
Journal of Acquired Immune Deficiency Syndromes|May 1, 1993
An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV diseaseT S Dyner, W Lang, J Geaga, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendationsF T Aweeka, M A Jacobson, S Martin-Munley, et al.
Lancet (London, England)|February 8, 1992
Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDSM A Jacobson, C L Besch, C Child, et al.
AIDS (London, England)|January 11, 2000
A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjectsJ B Angel, M A Jacobson, P R Skolnik, et al.
Neuroscience|September 11, 2002
Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptorsW-P Wu, J-X Hao, L Halldner-Henriksson, et al.
Pageof 15